Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if panitumumab, in combination with irinotecan,
leucovorin, and 5-fluorouracil (5-FU) is safe and efficacious in patients with metastatic
colorectal cancer.